Share on LinkedInShare on LinkedIn

ARTICLE · 25 FEBRUARY 2020

SEC Issues Guidance And Proposed Rules On MD&A

On January 30, 2020, the U.S. Securities and Exchange Commission ("SEC") provided guidance on the disclosure of key performance indicators ("KPIs") ...

United StatesCorporate/Commercial Law

On January 30, 2020, the U.S. Securities and Exchange Commission (“SEC”) provided guidance on the disclosure of key performance indicators (“KPIs”) in Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”). This guidance will become effective on the date of its publication in the Federal Register, which is expected shortly, and will be applicable to annual reports on Form 10-K and Form 20-F and quarterly reports on Form 10-Q.

As companies prepare for the 2020 annual reporting season, here are practice pointers based on the SEC’s guidance:

KPIs: KPIs should be disclosed in MD&A if necessary to an understanding of the company’s financial condition or results of operations, or if KPIs enhance a reader’s understanding of MD&A. In particular, any KPIs that a company already includes in earnings releases should also be considered for inclusion in the company’s MD&A. The SEC highlighted the following as examples of KPIs to which

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from